Suchergebnisse - "Mitnick, Carole D."

Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline von Nahid, Payam, Mase, Sundari R, Migliori, Giovanni Battista, Sotgiu, Giovanni, Bothamley, Graham H, Brozek, Jan L, Cattamanchi, Adithya, Cegielski, J Peter, Chen, Lisa, Daley, Charles L, Dalton, Tracy L, Duarte, Raquel, Fregonese, Federica, Horsburgh, Jr, C Robert, Ahmad Khan, Faiz, Kheir, Fayez, Lan, Zhiyi, Lardizabal, Alfred, Lauzardo, Michael, Mangan, Joan M, Marks, Suzanne M, McKenna, Lindsay, Menzies, Dick, Mitnick, Carole D, Nilsen, Diana M, Parvez, Farah, Peloquin, Charles A, Raftery, Ann, Schaaf, H Simon, Shah, Neha S, Starke, Jeffrey R, Wilson, John W, Wortham, Jonathan M, Chorba, Terence, Seaworth, Barbara

“… The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America …”
Weitere Angaben

Tuberculosis and chronic respiratory disease: a systematic review von Byrne, Anthony L., Marais, Ben J., Mitnick, Carole D., Lecca, Leonid, Marks, Guy B.

“… •We performed a systematic literature review to assess the association between a history of tuberculosis and chronic respiratory disease.•Overall there was a …”
Volltext

Comparing timelines and evidence available to support new TB, HIV, and HCV drug approvals: The same, only different von LaHood, Allison, Rahman, Rifat, McKenna, Lindsay, Frick, Mike, Mitnick, Carole D.

“… Background Tuberculosis (TB), human immunodeficiency virus (HIV), and hepatitis C virus (HCV) share a global presence and propensity to disproportionately …”
Volltext

Multidrug Resistant Pulmonary Tuberculosis Treatment Regimens and Patient Outcomes: An Individual Patient Data Meta-analysis of 9,153 Patients von Ahuja, Shama D., Ashkin, David, Avendano, Monika, Banerjee, Rita, Bauer, Melissa, Bayona, Jamie N., Becerra, Mercedes C., Benedetti, Andrea, Burgos, Marcos, Centis, Rosella, Chan, Eward D., Chiang, Chen-Yuan, Cox, Helen, D'Ambrosio, Lia, DeRiemer, Kathy, Dung, Nguyen Huy, Enarson, Donald, Falzon, Dennis, Flanagan, Katherine, Flood, Jennifer, Garcia-Garcia, Maria L., Gandhi, Neel, Granich, Reuben M., Hollm-Delgado, Maria G., Holtz, Timothy H., Iseman, Michael D., Jarlsberg, Leah G., Keshavjee, Salmaan, Kim, Hye-Ryoun, Koh, Won-Jung, Lancaster, Joey, Lange, Christophe, de Lange, Wiel C. M., Leimane, Vaira, Leung, Chi Chiu, Li, Jiehui, Menzies, Dick, Migliori, Giovanni B., Mishustin, Sergey P., Mitnick, Carole D., Narita, Masa, O'Riordan, Philly, Pai, Madhukar, Palmero, Domingo, Park, Seung-kyu, Pasvol, Geoffrey, Peña, Jose, Pérez-Guzmán, Carlos, Quelapio, Maria I. D., Ponce-de-Leon, Alfredo, Riekstina, Vija, Robert, Jerome, Royce, Sarah, Schaaf, H. Simon, Seung, Kwonjune J., Shah, Lena, Shim, Tae Sun, Shin, Sonya S., Shiraishi, Yuji, Sifuentes-Osornio, José, Sotgiu, Giovanni, Strand, Matthew J., Tabarsi, Payam, Tupasi, Thelma E., van Altena, Robert, Van der Walt, Martie, Van der Werf, Tjip S., Vargas, Mario H., Viiklepp, Pirett, Westenhouse, Janice, Yew, Wing Wai, Yim, Jae-Joon

“… Treatment of multidrug resistant tuberculosis (MDR-TB) is lengthy, toxic, expensive, and has generally poor outcomes. We undertook an individual patient data …”
Volltext

Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis von Jacobson, Karen R, Tierney, Dylan B, Jeon, Christie Y, Mitnick, Carole D, Murray, Megan B

“… The treatment of extensively drug-resistant tuberculosis (XDR TB) presents a major challenge. Second-line antimycobacterial drugs are less effective, more …”
Weitere Angaben

Comparison of censoring assumptions to reduce bias in tuberculosis treatment cohort analyses von Brooks, Meredith B., Mitnick, Carole D., Manjourides, Justin

“… Observational tuberculosis cohort studies are often limited by a lack of long-term data characterizing survival beyond the initial treatment outcome. Though …”
Volltext

The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens von Khan, Uzma, Huerga, Helena, Khan, Aamir J., Mitnick, Carole D., Hewison, Catherine, Varaine, Francis, Bastard, Mathieu, Rich, Michael, Franke, Molly F., Atwood, Sidney, Khan, Palwasha Y., Seung, Kwonjune J.

“… Background At a time when programs were struggling to design effective regimens for the treatment of multidrug-resistant tuberculosis (MDR-TB), the marketing …”
Volltext

Sputum culture reversion in longer treatments with bedaquiline, delamanid, and repurposed drugs for drug-resistant tuberculosis von Kho, Sooyeon, Seung, Kwonjune J., Huerga, Helena, Bastard, Mathieu, Khan, Palwasha Y., Mitnick, Carole D., Rich, Michael L., Islam, Shirajul, Zhizhilashvili, Dali, Yeghiazaryan, Lusine, Nikolenko, Elena Nikolaevna, Zarli, Khin, Adnan, Sana, Salahuddin, Naseem, Ahmed, Saman, Vargas, Zully Haydee Ruíz, Bekele, Amsalu, Shaimerdenova, Aiman, Tamirat, Meseret, Gelin, Alain, Vilbrun, Stalz Charles, Hewison, Catherine, Khan, Uzma, Franke, Molly

“… Sputum culture reversion after conversion is an indicator of tuberculosis (TB) treatment failure. We analyze data from the endTB multi-country prospective …”
Volltext

Selection bias in multidrug-resistant tuberculosis cohort studies assessing sputum culture conversion von Rodriguez, Carly A., Lodi, Sara, Horsburgh, C. Robert, Bastard, Mathieu, Hewison, Cathy, Huerga, Helena, Khan, Munira, Khan, Palwasha Y., Khan, Uzma, Oyewusi, Lawrence, Padayachee, Shrivani, Mitnick, Carole D., Franke, Molly F.

“… Conversion of sputum culture from positive to negative for M. tuberculosis is a key indicator of treatment response. An initial positive culture is a …”
Volltext

Keeping phase III tuberculosis trials relevant: Adapting to a rapidly changing landscape von Phillips, Patrick P. J., Mitnick, Carole D., Neaton, James D., Nahid, Payam, Lienhardt, Christian, Nunn, Andrew J.

“… In a Collection Review, Patrick Phillips and colleagues discuss developments in clinical trial design for the evaluation of TB therapeutics …”
Volltext

Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis von Campbell, Jonathon R., Falzon, Dennis, Mirzayev, Fuad, Jaramillo, Ernesto, Migliori, Giovanni Battista, Mitnick, Carole D., Ndjeka, Norbert, Menzies, Dick

“… International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from …”
Volltext

Low detection rate of RT-PCR-confirmed COVID-19 using IgM/IgG rapid antibody tests in a large community sample in Lima, Peru von Law, Stephanie, Tovar, Marco A., Franke, Molly F., Calderon, Roger, Palomino, Santiago, Valderrama, Gissella, Llanos, Fernando, Velásquez, Gustavo E., Mitnick, Carole D., Lecca, Leonid

“… Background Rapid IgM/IgG antibody tests were largely used in lieu of RT-PCR tests as part of COVID-19 public health response activities in Lima, Peru. To …”
Volltext

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis von Fox, Gregory J, Mitnick, Carole D, Benedetti, Andrea, Chan, Edward D, Becerra, Mercedes, Chiang, Chen-Yuan, Keshavjee, Salmaan, Koh, Won-Jung, Shiraishi, Yuji, Viiklepp, Piret, Yim, Jae-Joon, Pasvol, Geoffrey, Robert, Jerome, Shim, Tae Sun, Shin, Sonya S, Menzies, Dick, Ahuja, S, Ashkin, D, Avendaño, M, Banerjee, R, Bauer, M, Burgos, M, Centis, R, Cobelens, F, Cox, H, D'Ambrosio, L, de Lange, W C M, DeRiemer, K, Enarson, D, Falzon, D, Flanagan, K, Flood, J, Gandhi, N, Garcia-Garcia, L, Granich, R M, Hollm-Delgado, M G, Holtz, T H, Hopewell, P, Iseman, M, Jarlsberg, L G, Kim, H R, Lancaster, J, Lange, C, Leimane, V, Leung, C C, Li, J, Menzies, D, Migliori, G B, Narita, M, Nathanson, E, Odendaal, R, O'Riordan, P, Pai, M, Palmero, D, Park, S K, Pena, J, Pérez-Guzmán, C, Ponce-de-Leon, A, Quelapio, M I D, Quy, H T, Riekstina, V, Royce, S, Salim, M, Schaaf, H S, Seung, K J, Shah, L, Shean, K, Sifuentes-Osornio, J, Sotgiu, G, Strand, M J, Sung, S W, Tabarsi, P, Tupasi, T E, Vargas, M H, van Altena, R, van der Walt, M, van der Werf, T S, Westenhouse, J, Yew, W W

“… Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be used as an …”
Weitere Angaben

Revealing disparities in representation in knowledge generation and guideline development von Almeida, Carlos P. B., Andom, Afom T., Casseus, Alain, Do, Jacquelyn-My, Gelin, Alain, Lecca, Leonid, Luma, Maxo, Mazzi, Michael, Mitnick, Carole D., Mugunga, Jean Claude, Ndayizigiye, Melino, Nguyen, Natalie, Tamirat, Meseret, Tefera, Girum, Toussaint, Sterman, Tovar, Marco, Tzelios, Christine

“… Background Multidrug-resistant tuberculosis (MDR/RR-TB) is a major global health challenge, disproportionately affecting low- and lower-middle-income countries …”
Volltext

Comprehensive Treatment of Extensively Drug-Resistant Tuberculosis von Mitnick, Carole D, Shin, Sonya S, Seung, Kwonjune J, Rich, Michael L, Atwood, Sidney S, Furin, Jennifer J, Fitzmaurice, Garrett M, Alcantara Viru, Felix A, Appleton, Sasha C, Bayona, Jaime N, Bonilla, Cesar A, Chalco, Katiuska, Choi, Sharon, Franke, Molly F, Fraser, Hamish S.F, Guerra, Dalia, Hurtado, Rocio M, Jazayeri, Darius, Joseph, Keith, Llaro, Karim, Mestanza, Lorena, Mukherjee, Joia S, Muñoz, Maribel, Palacios, Eda, Sanchez, Epifanio, Sloutsky, Alexander, Becerra, Mercedes C

“… Important questions exist regarding the ability to treat extensively drug-resistant tuberculosis. In this study involving 48 patients in Peru who had …”
Volltext

Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study von Becerra, Mercedes C, Appleton, Sasha C, Franke, Molly F, Chalco, Katiuska, Arteaga, Fernando, Bayona, Jaime, Murray, Megan, Atwood, Sidney S, Mitnick, Carole D

“… Multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis have emerged as major global health threats. WHO recommends contact investigation …”
Volltext

Low body mass index as a predictor of sputum culture conversion and treatment outcomes among patients receiving treatment for multidrug-resistant tuberculosis in Lesotho von Oyewusi, Lawrence, Zeng, Chengbo, Seung, KJ, Mpinda, Stephanie, Kunda, Mikanda, Mitnick, Carole D, Kanu, Makelele, Tamirat, Meseret, Makaka, Joalane, Mofolo, Mabatloung, Maime, Refiloe, Maama, Llang, Senyo, Ninza, Oguntoyinbo, Bamidele, Mayombo, Lwayi, Franke, Molly F

“… A low body mass index (BMI) at the start of treatment for rifampicin- or multidrug-resistant tuberculosis (MDR/RR-TB) is associated with poor treatment …”
Volltext

Impact of out-of-pocket expenses for surgical care on households in rural Haiti: a mixed-methods study von Padovany, Michelson MN, Patterson, Rolvix H, Bowder, Alexis N, O'Brien, Eva, Alkire, Blake C, Katz, Arlene M, Mitnick, Carole D, Lu, Chunling

“… ObjectivesThis study aimed to report household catastrophic spending on surgery and the experiences of patients and families seeking surgical care in rural …”
Volltext

Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment von Franke, Molly F, Appleton, Sasha C, Bayona, Jaime, Arteaga, Fernando, Palacios, Eda, Llaro, Karim, Shin, Sonya S, Becerra, Mercedes C, Murray, Megan B, Mitnick, Carole D

“… Completing treatment for multidrug-resistant (MDR) tuberculosis (TB) may be more challenging than completing first-line TB therapy, especially in resource-poor …”
Weitere Angaben

Acquired and Transmitted Multidrug Resistant Tuberculosis: The Role of Social Determinants von Odone, Anna, Calderon, Roger, Becerra, Mercedes C., Zhang, Zibiao, Contreras, Carmen C., Yataco, Rosa, Galea, Jerome, Lecca, Leonid, Bonds, Matthew H., Mitnick, Carole D., Murray, Megan B.

“… Although risk factors for multi-drug resistant tuberculosis are known, few studies have differentiated between acquired and transmitted resistance. It is …”
Volltext